Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP
- 5 November 2004
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 324 (1), 269-275
- https://doi.org/10.1016/j.bbrc.2004.09.047
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clinical Applications of PET in OncologyRadiology, 2004
- Focus on hepatocellular carcinomaCancer Cell, 2004
- Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor-1α and its significanceJournal of Hepatology, 2004
- Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic interventionBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2002
- Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinaseCancer Letters, 2001
- Performance characteristics of the 3-D OSEM algorithm in the reconstruction of small animal PET imagesIEEE Transactions on Medical Imaging, 2000
- Initial results from a PET/planar small animal imaging systemIEEE Transactions on Nuclear Science, 1999
- Alkylation of isocitrate lyase from Escherichia coli by 3-bromopyruvateArchives of Biochemistry and Biophysics, 1990
- Tumor Mitochondria and the Bioenergetics of Cancer CellsPublished by S. Karger AG ,1977
- High aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinaseProceedings of the National Academy of Sciences of the United States of America, 1977